Burning Rock Biotech Ltd
BNR- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001792267
No open-market purchases or sales by Burning Rock Biotech Ltd insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $14.7M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Burning Rock Biotech Ltd as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- +1 vs. Q4 2023
- Shares held
- 20.6M
- +585.2K (+2.9%) vs. Q4 2023
- Total value
- $15.1M
- −$3.62M (−19.4%) vs. Q4 2023
- New holders
- 4
- 1 more added
- Sold out
- 3
- 8 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BNR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 17 | $14.7M |
| Q1 2026 | 16 | $27.4M |
| Q4 2025 | 16 | $34.9M |
| Q3 2025 | 16 | $12.4M |
| Q2 2025 | 17 | $4.57M |
| Q1 2025 | 18 | $9.65M |
| Q4 2024 | 21 | $15.8M |
| Q3 2024 | 18 | $6.69M |
| Q2 2024 | 18 | $13.2M |
| Q1 2024 | 20 | $15.1M |
| Q4 2023 | 19 | $18.7M |
| Q3 2023 | 28 | $20.1M |
| Q2 2023 | 32 | $46.2M |
| Q1 2023 | 34 | $60.8M |
| Q4 2022 | 42 | $49.6M |
| Q3 2022 | 52 | $55.5M |
| Q2 2022 | 50 | $71.2M |
| Q1 2022 | 46 | $274.5M |
| Q4 2021 | 62 | $243.0M |
| Q3 2021 | 87 | $490.9M |
| Q2 2021 | 86 | $793.4M |
| Q1 2021 | 54 | $634.7M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Burning Rock Biotech Ltd; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock Inc. | 65 | $47 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 83 | $60 | 0.00% | +83 | New |
| Shen Neil Nanpeng | 885 | $761 | 0.52% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 1,201 | $876 | 0.00% | +1,201 | New |
| Rhumbline Advisers | 5,805 | $4.23K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 12,558 | $9.16K | 0.00% | +12,558 | New |
| Susquehanna International Group, LLP | 19,084 | $13.9K | 0.00% | +19,084 | New |
| Geode Capital Management, LLC | 25,600 | $18.7K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 49,020 | $35.7K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 66,962 | $48.8K | 0.00% | −55−0.1% | Reduced |
| Morgan Stanley | 223,881 | $163.0K | 0.00% | −95,929−30.0% | Reduced |
| SC China Holding Ltd | 212,121 | $182.2K | 0.02% | 00.0% | Unchanged |
| Bank of America Corp | 292,868 | $213.2K | 0.00% | −660.0% | Reduced |
| Renaissance Technologies LLC | 342,700 | $250.0K | 0.00% | −2,600−0.8% | Reduced |
| Nikko Asset Management Americas, Inc. | 591,428 | $419.9K | 0.00% | −75,637−11.3% | Reduced |
| Sumitomo Mitsui Trust Holdings, Inc. | 591,428 | $430.6K | 0.00% | −75,637−11.3% | Reduced |
| Millennium Management LLC | 1,737,208 | $1.27M | 0.00% | −4,820−0.3% | Reduced |
| FIL Ltd | 2,808,981 | $2.05M | 0.00% | 00.0% | Unchanged |
| Massachusetts Financial Services Co | 4,026,892 | $2.93M | 0.00% | −18,218−0.5% | Reduced |
| Kynam Capital Management, LP | 9,640,914 | $7.02M | 0.78% | +946,488+10.9% | Added |
| Redwood Wealth Management Group, LLC | 0 | $0 | 0.00% | −109,542−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −11,023−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −664−100.0% | Sold out |